First-trimester increase in oxidative stress and risk of small-for-gestational-age fetus

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 116, Issue 5, 2009, Pages 637-642

  Potdar, N ^a   Singh, R ^b   Mistry, V ^a   Evans, M D ^a   Farmer, P B ^b   Konje, J C ^a   Cooke, M S ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

8 dihydro 2 deoxyguanosine; 8 oxo 7; DNA damage; Fetal growth restriction; Oxidative stress; Placenta; Pregnancy

Indexed keywords

8 HYDROXYDEOXYGUANOSINE;

ADULT; ARTICLE; BIRTH WEIGHT; CONTROLLED STUDY; FEMALE; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HUMAN; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; OXIDATIVE STRESS; PRIORITY JOURNAL; SMALL FOR DATE INFANT; TANDEM MASS SPECTROMETRY; TEACHING HOSPITAL; UNITED KINGDOM; URINALYSIS;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; BIRTH WEIGHT; CASE-CONTROL STUDIES; COTININE; DEOXYGUANOSINE; FEMALE; FETAL GROWTH RETARDATION; FOLLOW-UP STUDIES; HUMANS; OXIDATIVE STRESS; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY TRIMESTER, SECOND; PROSPECTIVE STUDIES; RISK ASSESSMENT; SALIVA; SMOKING; STATISTICS, NONPARAMETRIC;

EID: 62149127296     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.2008.02096.x     Document Type: Article

References (34)

1. Cnattingius S, Haglund B, Kramer MS. Differences in late fetal death rates in association with determinants of small for gestational age fetuses: population based cohort study. BMJ 1998 31 : 1483 7.
2. Froen JF, Gardosi JO, Thurmann A, Francis A, Stray-Pedersen B. Restricted fetal growth in sudden intrauterine unexplained death. Acta Obstet Gynecol Scand 2004 83 : 801 7.
3. Gardosi J, Badger S, Tonks A, Francis A. "Unexplained" stillbirths: an investigation of the clinically relevant conditions at the time of fetal death. Am J Obstet Gynecol 2003 189 : S158.
4. Gardosi J. Customized fetal growth standards: rationale and clinical application. Semin Perinatol 2004 28 : 33 40.
5. Barker DJ. The fetal and infant origins of adult disease. BMJ 1990 301 : 1111.
6. Barker DJ. Fetal origins of coronary heart disease. BMJ 1995 311 : 171 4.
7. Gluckman PD, Hanson MA, Morton SM, Pinal CS. Life-long echoes - a critical analysis of the developmental origins of adult disease model. Biol Neonate 2005 87 : 127 39.
8. Maulik D. Fetal growth restriction: the etiology. Clin Obstet Gynecol 2006 49 : 228 35.
9. Sies H. Oxidative stress: oxidants and antioxidants. Exp Physiol 1997 82 : 291 5.
10. Cooke MS, Evans MD, Dove R, Rozalski R, Gackowski D, Siomek A, et al. DNA repair is responsible for the presence of oxidatively damaged DNA lesions in urine. Mutat Res 2005 574 : 58 66.
11. Cooke MS, Olinski R, Evans MD. Does measurement of oxidative damage to DNA have clinical significance? Clin Chim Acta 2006 365 : 30 49.
12. Kasai H. Analysis of a form of oxidative DNA damage, 8-hydroxy-2'- deoxyguanosine, as a marker of cellular oxidative stress during carcinogenesis. Mutat Res 1997 387 : 147 63.
13. Wisdom SJ, Wilson R, McKillop JH, Walker JJ. Antioxidant systems in normal-pregnancy and in pregnancy-induced hypertension. Am J Obstet Gynecol 1991 165 : 1701 4.
14. Jauniaux E, Watson AL, Hempstock J, Bao YP, Skepper JN, Burton GJ. Onset of maternal arterial blood flow and placental oxidative stress - a possible factor in human early pregnancy failure. Am J Pathol 2000 157 : 2111 22.
15. Myatt L, Cui XL. Oxidative stress in the placenta. Histochem Cell Biol 2004 122 : 369 82.
16. CARE Study Group. Maternal caffeine intake during pregnancy and risk of fetal growth restriction: a large prospective observational study. BMJ 2008 337 : a2332. doi: 10.1136/bmj.a2332.
17. Gardosi J, Chang A, Kalyan B, Sahota D, Symonds EM. Customised antenatal growth charts. Lancet 1992 339 : 283 7.
18. Loft S, Moller P. Oxidative DNA damage and human cancer: need for cohort studies. Antioxid Redox Signal 2006 8 : 1021 31.
19. Cooke MS, Singh R, Hall GK, Mistry V, Duarte TL, Farmer PB, et al. Evaluation of enzyme-linked immunosorbent assay and liquid chromatography-tandem mass spectrometry methodology for the analysis of 8-oxo-7,8-dihydro-2'- deoxyguanosine in saliva and urine. Free Radic Biol Med 2006 41 : 1829 36.
20. Hu CW, Wang CJ, Chang LW, Chao MR. Clinical-scale high-throughput analysis of urinary 8-oxo-7,8-dihydro-2'-deoxyguanosine by isotope-dilution liquid chromatography-tandem mass spectrometry with on-line solid-phase extraction. Clin Chem 2006 52 : 1381 8.
21. Lin HS, Jenner AM, Ong CN, Huang SH, Whiteman M, Halliwell B. A high-throughput and sensitive methodology for the quantification of urinary 8-hydroxy-2'-deoxyguanosine: measurement with gas chromatography-mass spectrometry after single solid-phase extraction. Biochem J 2004 380 : 541 8.
22. Agostoni C, Galli C, Riva E, Colombo C, Giovannini M, Marangoni F. Reduced docosahexaenoic acid synthesis may contribute to growth restriction in infants born to mothers who smoke. J Pediatr 2005 147 : 854 6.
23. DeMarini DM. Genotoxicity of tobacco smoke and tobacco smoke condensate: a review. Mutat Res 2004 567 : 447 74.
24. Noakes PS, Thomas R, Lane C, Mori TA, Barden AE, Devadason SG, et al. Association of maternal smoking with increased infant oxidative stress at 3 months of age. Thorax 2007 62 : 714 17.
25. Etter JF, Duc TV, Perneger TV. Saliva cotinine levels in smokers and nonsmokers. Am J Epidemiol 2000 151 : 251 8.
26. Scholl TO, Stein TP. Oxidant damage to DNA and pregnancy outcome. J Matern Fetal Med 2001 10 : 182 5.
27. Hoang VM, Foulk R, Clauser K, Burlingame A, Gibson BW, Fisher SJ. Functional proteomics: examining the effects of hypoxia on the cytotrophoblast protein repertoire. Biochemistry 2001 40 : 4077 86.
28. Bogdanov MB, Beal MF, McCabe DR, Griffin RM, Matson WR. A carbon column-based liquid chromatography electrochemical approach to routine 8-hydroxy-2'-deoxyguanosine measurements in urine and other biologic matrices: a one-year evaluation of methods. Free Radic Biol Med 1999 27 : 647 66.
29. Arguelles S, Machado MJ, Ayala A, Machado A, Hervias B. Correlation between circulating biomarkers of oxidative stress of maternal and umbilical cord blood at birth. Free Radic Res 2006 40 : 565 70.
30. Kim YJ, Hong YC, Lee KH, Park HJ, Park EA, Moon HS, et al. Oxidative stress in pregnant women and birth weight reduction. Reprod Toxicol 2005 19 : 487 92.
31. Longini M, Perrone S, Kenanidis A, Vezzosi P, Marzocchi B, Petraglia F, et al. Oxidative stress in amniotic fluid of pregnancies with fetal growth retardation. Pediatr Res 2004 56 : 471.
32. Sharma JB, Sharma A, Bahadur A, Vimala N, Satyam A, Mittal S. Oxidative stress markers and antioxidant levels in normal pregnancy and pre-eclampsia. Int J Gynaecol Obstet 2006 94 : 23 7.
33. Takagi Y, Nikaido T, Toki T, Kita N, Kanai M, Ashida T, et al. Levels of oxidative stress and redox-related molecules in the placenta in preeclampsia and fetal growth restriction. Virchows Arch 2004 444 : 49 55.
34. Walsh SW, Vaughan JE, Wang Y, Roberts LJ. Placental isoprostane is significantly increased in preeclampsia. FASEB J 2000 14 : 1289 96.